Blocking Caspase-2 (the liver’s guardian enzyme) to treat fatty liver may produce chronic damage and multiply the risk of ...

Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead increase the risk of chronic liver damage and cancer as we age. In a major new ...

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...

Oncoguard® Liver blood test delivers six times greater sensitivity for very early-stage hepatocellular carcinoma (HCC) versus standard of care. These findings will be presented as late-breaking data ...

Researchers have discovered new treatments to suppress the growth of cancers of the bowel and liver. Researchers at the Cancer Research UK Scotland Institute in Glasgow studied genes which can cause ...

The Union of Local Authorities of the Philippines (ULAP) today called on the Department of Health (DOH) to arrest the rising mortality of liver cancer and integrate innovative medicines and value-base ...

MASH-related liver cancer cases, deaths, and DALYs have surged significantly from 1990 to 2021, with men experiencing a higher burden than women. Geographic disparities show East Asia, South Asia, and ...

Yellow Warriors Society Philippines calls on the Department of Health and PhilHealth to expand access to modern liver cancer ...

The liver is one of the most important organs in the human body. It performs critical functions such as filtering blood, producing essential proteins, storing energy, and removing toxins. It also ...

ALTUS study is the largest prospective trial of a blood test for liver cancer surveillance in the United States, reflecting the racial and ethnic diversity of high-risk groups Exact Sciences Corp.